|Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors|
C Papi, F Fascì-Spurio, F Rogai, A Settesoldi, G Margagnoni, V Annese
Digestive and Liver Disease 45 (12), 978-985, 2013
|Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?|
FF Spurio, A Aratari, G Margagnoni, MT Doddato, C Papi
Journal of Gastrointestinal & Liver Diseases 21 (1), 2012
|Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16–50 years|
NA Kennedy, A Clark, A Walkden, JCW Chang, F Fascí-Spurio, M Muscat, ...
Journal of Crohn's and Colitis 9 (1), 41-49, 2015
|Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?|
F Fascì Spurio, A Aratari, G Margagnoni, V Clemente, A Moretti, C Papi
Journal of Gastrointestinal & Liver Diseases 22 (1), 2013
|Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn’s disease|
F Fascì Spurio, A Aratari, G Margagnoni, M Teresa Doddato, F Chiesara, ...
Current Clinical Pharmacology 7 (2), 131-136, 2012
|Natural history of ileo-caecal Crohn’s disease after surgical resection. A long term study|
G Margagnoni, A Aratari, M Mangone, A Moretti, A Spagnolo, ...
Minerva Gastroenterol Dietol 57 (4), 335-344, 2011
|The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology|
C Bezzio, F Fascì-Spurio, C Viganò, G Meucci, C Papi, S Saibeni
Expert review of gastroenterology & hepatology 11 (1), 33-41, 2017
|Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?|
S Saibeni, G Meucci, C Papi, G Manes, F Fascì-Spurio
Expert Review of Gastroenterology & Hepatology 8 (8), 949-962, 2014
|Randomized Controlled Trials in Prevention of PostSurgical Recurrence in Crohn's Disease|
C Papi, F Fasci Spurio, G Margagnoni, A Aratari
Reviews on Recent Clinical Trials 7 (4), 307-313, 2012
|Long term course of ulcerative colitis in the prebiologic era. A retrospective study in a tertiary referral center.|
G Margagnoni, F Fascì Spurio, L Feigusch, M Koch, C Papi, A Aratari
Minerva gastroenterologica e dietologica 60 (4), 275-283, 2014
|564 Elevated Faecal Calprotectin Predicts Disease Progression in Crohn's Disease|
NA Kennedy, J Chang, M Guy, T Smith, JT Loh, D Haunschmidt, M Muscat, ...
Gastroenterology 144 (5), S-105, 2013
|The use of oral corticosteroids in inflammatory bowel diseases in Italy: an IG-IBD survey|
F Fascì-Spurio, G Meucci, C Papi, S Saibeni
Digestive and Liver Disease 49 (10), 1092-1097, 2017
|Sight-threatening Keratopathy Complicating Anti-TNF Therapy in Crohn's Disease: A Case Report|
F Fasci-Spurio, A Thompson, S Madill, P Koay, D Mansfield, J Satsangi
Inflammatory Bowel Diseases 20 (1), E2-E3, 2014
|P221 Faecal calprotectin concentrations in Crohn's patients with ileal disease location: correlations with disease activity as seen by MRI enterography|
F Fascì-Spurio, A Chiappini, V Buonocore, S Cannizzaro, Z Maddalena, ...
Journal of Crohn's and Colitis 8 (Supplement_1), S154-S155, 2014
|Screening for active COVID-19 infection prior to biologic therapy in IBD patients: let's not increase our uncertainty without reducing our concerns|
S Festa, A Aratari, F De Biasio, FF Spurio, C Papi
Digestive and Liver Disease, 2020
|Faecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn’s Disease: Correlations Between Disease Activity and Long-Term Follow-Up|
GR Jones, F Fascì-Spurio, NA Kennedy, N Plevris, P Jenkinson, M Lyons, ...
Journal of Crohn's and Colitis 13 (4), 442-450, 2019
|A new form of chronic inflammatory bowel disease associated with chronic liver disease|
F Fascì-Spurio, P Pavlidis, I Bjarnason
Scandinavian Journal of Gastroenterology 51 (6), 644-645, 2016
|Tu1132 Correlation of Clinical Symptoms to Current Biomarkers of Intestinal Inflammation in Patients With Crohn's Disease|
J Chang, NA Kennedy, FF Spurio, M Muscat, MGT Smith, JT Loh, ...
Gastroenterology 144 (5), S-770, 2013
|P250 Elevated faecal calprotectin predicts disease progression in Crohn's disease|
NA Kennedy, J Chang, MH Guy, T Smith, JT Loh, D Haunschmidt, ...
Journal of Crohn's and Colitis 7 (Supplement_1), S109-S110, 2013
|P266 Correlation of clinical symptoms to current biomarkers of intestinal inflammation in patients with Crohn's disease|
J Chang, N Kennedy, F Fascí Spurio, M Muscat, M Guy, J Satsangi, ...
Journal of Crohn's and Colitis 7 (Supplement_1), S116-S116, 2013